Clinical Experiences With the Anticoagulant Coumadin (Warfarin) Sodium

Abstract

Get full access to this article

View all access options for this article.

References

Goodman, L.S. , AND Gilman, A. : The Pharmacologic Basis of Therapeutics, 2nd edition, p. 1520. Macmillan, New York, 1955.

Clatanoff, D.V. , Triggs, P.O. , AND Meyer, O.O. : Clinical experiences with Warfarin and warfarin sodium. Arch. Int. Med., 94: 213, 1954.

Pollock, B.E. : Clinical experience with warfarin (Coumadin) sodium, a new anticoagulant. J. A. M. A., 159: 1094, 1955 ; and The early management of myocardial infarction, J. A. M. A. 161: 404, 1956.

Shapiro, S. : Warfarin sodium derivative: (Coumadin sodium)—an intravenous hypoprothrombinemia-inducing agent. Angiology 4: 380, 1953; and The hypoprothrombinemia-inducing activity of warfarin (Coumadin) sodium. J. Kansas M. Soc. , 55: 687, 1954 .

Wolff, J.M. , Barker, N.W. , Gifford, R.W. , AND Mann, F.D. : Experiences with a new intravenous coumarin anticoagulant (warfarin sodium derivative). Proc. Staff Meet. Mayo Clin., 28: 489, 1953.

Nichol, E.S. , In Current Therapy, 1954, p. 199. W. B. Saunders Co., Philadelphia, and Nichol, E.S. , Philips, W.C. , and Jenkins, V.E. : Anticoagulants in coronary heart disease. M. Clin. North America 38: 399, 1954.

Freeman, D.J. , AND Meyer, O.O. : Rectal administration of warfarin (Coumadin) sodium (sodium [3(2-acetonyl-benzyl)-4-hydroxycoumarin]). Proc. Soc. Exper. Biol. & Med., 92: 52, 1956.